Syncom Formulations Share Price

Syncom Formulations Share Price

NSE: SYNCOMF
|
Pharmaceuticals

₹ 22.26

-₹0.98 (-4.22%)
1D
Last updated 13 Oct, 2026, 15:58 IST

Syncom Formulations Share Price Today

As of 14 Oct 2026, Syncom Formulations share price is ₹22.26. The stock opened at ₹23.24, compared to its previous close of ₹23.24. During today's trading session, Syncom Formulations share price moved in the range of ₹21.75 to ₹23.26, with an average price of ₹22.51 for the day. Looking at its last 52-week, the stock has touched a low of ₹10.21 and a high of ₹27.49. On the performance front, Syncom Formulations share price has increased by 66.49% over the last six months and is up 33.85% on a year-on-year basis.

₹21.75
4.22% down today
₹23.26
1D LOW
1D HIGH

Syncom Formulations Returns Calculator

Volume
1,44,74,298
Average traded price
₹22.22
Last traded time
03:58:50 13 Oct
Last traded quantity
1
Circuit
L
H
₹18.60
₹27.88
52-week
L
H
₹10.21
₹27.49
Mkt Cap Cr
2,180.80
P/E
24.48
P/B
5.05
ROA
16.02%
ROE
18.42%
ROCE
24.46%
Quick Ratio
2.58
EV/EBITDA
18.02
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Syncom Formul. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Syncom Formul. appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Syncom Formul. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0134.835.0511.19%13.74%17.33%2.3121.42
Divis Laboratories2,48,982.9885.1214.8514.6%15.32%19.56%3.556.28
Torrent Pharmaceuticals1,76,300.5082.5521.164.87%25.49%13.85%0.7538.11
Zydus Lifesciences1,13,615.6924.744.198.57%18.59%17.35%0.9114.87
Laurus Labs1,11,898.66102.6321.1110.38%16.77%16.14%0.6853.86
Cipla1,06,129.9631.623.087.92%11.27%14.95%2.517.83
Dr. Reddy's Laboratories1,02,707.4132.262.75.48%11.07%12.54%1.3515.86
Mankind Pharma99,089.5247.926.087.36%11.74%13.13%0.7425.7
Aurobindo Pharma97,972.4726.42.596.34%9.25%11.76%1.1512.47
Lupin89,628.8316.033.9614.47%23.76%24.88%1.429.56

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Syncom Formulations

Syncom Formulations Share Price
ISIN
INE312C01025
Sector Market Cap
₹ 2,180.80 Cr

Syncom Formulations (India) Limited is engaged in manufacturing pharmaceutical drugs and formulation and trading commodities. The company also has business interests in renting and leasing properties. It manufactures and markets over 500 pharmaceutical drugs in various dosage forms, including tablets, liquid orals, vials, capsules, ointments, dry powder and ampoule injections. Syncom Formulations's manufacturing facility is located in Madhya Pradesh's Pithampur. Established in 1995, the unit is equipped with modern machinery and has WHO-GMP and ISO 9001-2015 certification. The company's marketing network is established in nearly 25 countries, selling over 400 registered drugs.

Business operations

Syncom Formulations (India) was originally incorporated as a private company in 1988. It became a public entity in 1992. The company set up its first manufacturing facility in Mahrashtra's Palghar and began production in 1989. As part of its expansion efforts, it set up a new unit in Madhya Pradesh's Pithampur. The company raised funds for this facility through a public issue made in 1994. In 1998, the company introduced a range of prescription formulations. The next year, the company expanded its production capacity and further introduced new products. By 2000, the company was exporting drugs to Guinea, Ghana, Kenya, Tanzania, Nigeria, Azerbaijan, Nepal and Sri Lanka.

The company also received approval as a supplier to Central ESI Hospitals and was registered for defence services, resulting in improved sales volume. The company entered into the herbal products segments, boosting its manufacturing and marketing of products like Edicare Attom Megacaps Ecziguard and Yas antacid salt.

Syncom Formulations expanded its tablet division by introducing high-speed mega press machines. The company increased its capacity in the tablet section by over 30% and nearly doubled its capacity in the capsule section.

The company launched a new division Cratus Life Care in 2007. This division is involved in looking after the domestic market's needs. The name is derived from Hippocrates - known as the Father of Medicine. The company later entered the specialist segment of “Reproductive Medicine & Women’s Care” by launching a dedicated division Cratus Evolve.

As of January 19, 2024, Syncom Formulations (India) Limited's market capitalisation is valued at over ₹1,400 crore. Syncom Formulations share price has moved up by over 300% in the last three years.

Syncom Formulations Financial Highlights

  • Revenue: Syncom Formulations reported revenue of ₹520.51 crore in FY26 vs ₹482.44 crore in FY25. It showed an increase of 7.89% on a yearly basis.
  • Operating Profit: Syncom Formulations reported an operating profit of ₹101.12 crore in FY26 vs ₹65.51 crore in FY25. It showed an increase of 54.36% on a year-on-year basis.
  • Net Profit: Syncom Formulations reported a net profit of ₹76.44 crore in FY26 vs ₹49.43 crore in FY25. It showed an increase of 54.64% on a yearly basis.

Syncom Formulations Quarterly Result Highlights

  • Syncom Formulations reported revenue of ₹133.36 crore in Jun 2026, compared with ₹149.96 crore in Mar 2026, representing a decrease of 11.07% on a quarter-on-quarter (QoQ) basis.
  • Syncom Formulations reported an operating profit of ₹32.25 crore in Jun 2026, compared with ₹33.70 crore in Mar 2026, representing a decrease of 4.30% on a quarter-on-quarter (QoQ) basis.
  • Syncom Formulations reported a profit of ₹24.85 crore in Jun 2026, compared with ₹25.17 crore in Mar 2026, reflecting a decrease of 1.27% on a QoQ basis.
  • The earnings per share (EPS) of Syncom Formulations stood at ₹0.81 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
50.57%
FII
0.35%
Other DII
0.00%
Retail and other
49.08%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.10%
Dec 20250.26%
Mar 20260.21%
Jun 20260.35%
1 day
-4.22%
1 week
-4.13%
1 month
+14.39%
1 year
+33.85%
3 years
+148.72%
5 years
+174.81%
Day
Open / Close
Change %
13 Oct 26
₹23.24 / ₹22.26
-4.22%
12 Oct 26
₹23.29 / ₹23.24
-0.17%
09 Oct 26
₹23.73 / ₹23.28
-1.23%
08 Oct 26
₹25.19 / ₹23.57
-5.49%
Show more

Syncom Formulations Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹489.17₹465.01₹263.39₹224.25
Other Income₹31.34₹17.43₹13.53₹14.60
Total Revenue₹520.51₹482.45₹276.91₹238.85
Total Expenses₹419.43₹416.94₹242.94₹212.29
Profit Before Tax₹101.12₹65.51₹33.95₹26.57
Tax₹24.68₹16.08₹8.64₹6.50
Profit After Tax₹76.44₹49.43₹25.31₹20.07
EPS - Basic₹0.81₹0.53₹0.34₹0.24
EPS - Diluted₹0.81₹0.53₹0.34₹0.24

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹101.08₹65.51₹33.98₹26.56
Income before WC changes₹70.88₹54.31₹30.49₹20.45
Change in Assets-₹37.47-₹36.82-₹32.43-₹12.77
Change in Liabilities₹47.54₹20.69₹4.06₹9.51
Change in WC₹10.07-₹16.13-₹28.37-₹3.26
Cash flow from Operations₹58.08₹23.44-₹5.96₹10.53
Cash flow from Investing-₹50.62-₹18.20₹83.02-₹44.95
Cash flow from Financing-₹3.02-₹67.90-₹14.56₹35.00
Total Cash Flow₹4.44-₹62.67₹62.50₹0.58
Cash (Start of the year)₹0.71₹63.38₹0.88₹0.30
Cash (End of the year)₹5.15₹0.71₹63.38₹0.88

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹203.48₹143.31₹129.88₹196.14
Current Assets₹330.37₹269.97₹274.78₹181.69
Total Assets₹533.85₹413.28₹404.66₹377.83
Current Liabilities₹103.73₹59.31₹106.52₹113.16
Net Current Asset₹226.64₹210.66₹168.26₹68.53
Non-Current Liabilities₹15.13₹11.81₹10.00₹8.66
Equity Capital₹414.99₹342.16₹288.14₹256.01
Total Equity & Liabilities₹533.85₹413.28₹404.66₹377.83

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹486.57₹462.85₹258.36₹224.64
Other Income₹30.97₹17.19₹13.10₹14.61
Total Revenue₹517.54₹480.04₹271.46₹239.25
Total Expenses₹417.05₹415.39₹239.68₹212.70
Profit Before Tax₹100.53₹64.66₹31.76₹26.57
Tax₹24.52₹15.79₹8.14₹6.50
Profit After Tax₹76.01₹48.87₹23.62₹20.07
EPS - Basic₹0.81₹0.52₹0.32₹0.24
EPS - Diluted₹0.81₹0.52₹0.32₹0.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹100.49₹64.65₹31.78₹26.55
Income before WC changes₹70.60₹53.69₹28.52₹20.43
Change in Assets-₹36.84-₹46.45-₹21.18-₹11.91
Change in Liabilities₹47.23₹30.53-₹5.69₹8.63
Change in WC₹10.39-₹15.92-₹26.87-₹3.28
Cash flow from Operations₹58.29₹23.31-₹5.94₹10.50
Cash flow from Investing-₹50.64-₹18.38₹83.83-₹44.97
Cash flow from Financing-₹3.22-₹67.59-₹15.37₹35.00
Total Cash Flow₹4.43-₹62.66₹62.52₹0.53
Cash (Start of the year)₹0.69₹63.35₹0.83₹0.30
Cash (End of the year)₹5.12₹0.69₹63.35₹0.83

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹203.23₹142.22₹128.86₹196.17
Current Assets₹326.03₹267.46₹262.64₹180.77
Total Assets₹529.26₹409.69₹391.50₹376.94
Current Liabilities₹101.83₹57.97₹95.05₹112.27
Net Current Asset₹224.21₹209.49₹167.59₹68.50
Non-Current Liabilities₹15.13₹11.81₹10.00₹8.66
Equity Capital₹412.30₹339.90₹286.45₹256.01
Total Equity & Liabilities₹529.26₹409.69₹391.50₹376.94
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
22.26
2931
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 2931
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
58.65
Neutral
ATR (14)
2.02
Neutral
STOCH(9,6)
22.16
Neutral
STOCH RSI (14)
0
Bullish
ADX(9)
39.13
Bearish
UO(9)
49.88
Neutral
ROC(12)
16.14
Bullish
WillR(14)
-53.93
Neutral
Period
Simple value
Exponential vaue
5D
23.65
23.49
10D
23.88
23.18
20D
21.72
22.13
50D
18.77
19.62
100D
16.43
17.48
Volume trend — traded volume by day
13 Oct1Cr
12 Oct1Cr
9 Oct1Cr
8 Oct1Cr
7 Oct4Cr
Average2Cr

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Syncom Formulations Share Price
Syncom Formulations
Pharmaceuticals
Add Stock
Add Another

Syncom Formulations Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.